Figure 3.
Management of nonadvanced SM. PROs, patient-reported outcomes. Adapted from Gerds AT, Gotlib J, Ali H, et al. Systemic mastocytosis, version 1.2022, https://www.nccn.org/guidelines. Clinical Practice in Oncology (NCCN Guidelines): National Comprehensive Cancer Network; 2022.